Evidence map›Paper›PMID 35487707›Full record

ArticleBMJ open2022

Exemplars in vaccine delivery protocol: a case-study-based identification and evaluation of critical factors in achieving high and sustained childhood immunisation coverage in selected low-income and lower-middle-income countries.

Robert A Bednarczyk, Kyra A Hester, Sameer M Dixit, Anna S Ellis, Cam Escoffery, William Kilembe, Katie Micek, Zoë M Sakas, Moussa Sarr, Matthew C Freeman

Abstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Robert A BednarczykHubert Department of Global Health, Rollins School of Public Health, Atlanta, Georgia, USA rbednar@emory.edu.ORCID 0000-0002-6812-0928
Kyra A HesterGangarosa Department of Environmental Health, Emory University Rollins School of Public Health, Atlanta, Georgia, USA.
Sameer M DixitCenter for Molecular Dynamics, Kathmandu, Nepal.
Anna S EllisGangarosa Department of Environmental Health, Emory University Rollins School of Public Health, Atlanta, Georgia, USA.
Cam EscofferyDepartment of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Atlanta, Georgia, USA.
William KilembeZambia Emory HIV Research Project, Lusaka, Zambia.
Katie MicekGangarosa Department of Environmental Health, Emory University Rollins School of Public Health, Atlanta, Georgia, USA.
Zoë M SakasGangarosa Department of Environmental Health, Emory University Rollins School of Public Health, Atlanta, Georgia, USA.
Moussa SarrInstitut de Recherche et Santé de Épidémiologique et de Formations, Dakar, Senegal.ORCID 0000-0003-2372-6632
Matthew C FreemanGangarosa Department of Environmental Health, Emory University Rollins School of Public Health, Atlanta, Georgia, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIncreases in global childhood vaccine delivery have led to decreases in morbidity from vaccine-preventable diseases. However, these improvements in vaccination have been heterogeneous, with some countries demonstrating greater levels of change and sustainability. Understanding what these high-performing countries have done differently and how their decision-making processes will support targeted improvements in childhood vaccine delivery. METHODS AND ANALYSIS: We studied three countries-Nepal, Senegal, Zambia-with exemplary improvements in coverage between 2000 and 2018 as part of the Exemplars in Global Health Programme. We apply established implementation science frameworks to understand the 'how' and 'why' underlying improvements in vaccine delivery and coverage. Through mixed-methods research, we will identify drivers of catalytic change in vaccine coverage and the decision-making process supporting these interventions and activities. Methods include quantitative analysis of available datasets and in-depth interviews and focus groups with key stakeholders in the global, national and subnational government and non-governmental organisation space, as well as community members and local health delivery system personnel. ETHICS AND DISSEMINATION: Working as a multinational and multidisciplinary team, and under oversight from all partner and national-level (where applicable) institutional review boards, we collect data from participants who provided informed consent. Findings are disseminated through a variety of forms, including peer-reviewed manuscripts related to country-specific case studies and vaccine system domain-specific analyses, presentations to key stakeholders in the global vaccine delivery space and narrative dissemination on the Exemplars.Health website.

Indexed as

Vaccination CoverageVaccinesDeveloping CountriesHumansImmunization ProgramsIncomeVaccinesInternational health servicesPaediatric infectious disease & immunisationPUBLIC HEALTH

Identifiers

PMID35487707
PMCPMC9058776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.